Page 980 - Clinical Small Animal Internal Medicine
P. 980

918  Section 9  Infectious Disease

              Epidemiology                                      Therapy
  VetBooks.ir  Wolbachia is ubiquitous in D. immitis, being present in   Because of the symbiotic relationship between Wolbachia


            100% of the helminths. Therefore, the distribution of
                                                              genesis, maturation, and survival of heartworm. Treating
            Wolbachia follows the presence of D. immitis, which is   and D. immitis, decreased bacterial load affects embryo-
            endemic in North, Central, and South America, the coastal   dogs infected with D. immitis with an antibiotic that tar-
            regions of Africa, southern Europe, India, north, central‐  gets Wolbachia results in a decrease in microfilaremia, and
            east and south China, Southeast Asia, and Australia.   when combined with ivermectin, fewer pathologic pulmo-
            Updated prevalence maps for heartworm are available at   nary lesions are observed compared to adulticide therapy
            the Canine Vector‐Borne Disease World Forum website   alone  (melarsomine).  Therefore,  the  current  therapeutic
            (www.cvbd.org/en/occurrence‐maps/world‐map/).     recommendation from the American Heartworm Society
                                                              is to administer doxycycline at 10 mg/kg PO BID for four
                                                              weeks in combination with ivermectin prior to adulticide
              Signalment                                      therapy. Doxycycline eliminates >90% of the  Wolbachia
                                                              organisms from the nematode for at least three months.
            Because of the life cycle of D. immitis, clinical signs are
            generally detected in animals older than 1 year. Dogs are
            more frequently affected than cats.                 Prognosis

                                                              Because all D. immitis are infected with Wolbachia, the
              History and Clinical Signs                      prognosis of Wolbachia infection follows the prognosis
                                                              for treatment of heartworm infections. Patients with no
            While Wolbachia may collaborate in the pathogenesis of   abnormal physical examination findings or radiographic
            D. immitis infection, clinical signs are indistinguishable   changes have an excellent prognosis. Those with mild
            from heartworm disease.                           clinical signs and mild thoracic radiograph abnormalities
                                                              have a good prognosis if adequately treated. Patients
                                                              with moderate to severe disease, including caval syn-
              Diagnosis                                       drome, have a poor prognosis.

            Wolbachia DNA can be detected using polymerase chain
            reaction (PCR) on EDTA–anticoagulated blood samples.     Public Health Implications
            Interestingly, using PCR to detect Wolbachia has been
            proposed as a tool to detect early D. immitis infection.   Dirofilaria immitis is able to infect humans, where it
            WSP can also be detected using serology, but because all   generally causes granulomatous lesions in lungs and
            D. immitis stages are infected with Wolbachia, the pres-  subcutaneous tissue. Similar to what has been docu-
            ence of the organism is assumed in a dog with a positive   mented in dogs and cats, inflammatory reactions to
            test for occult heartworm antigen. Interestingly, one   these parasites in humans may be associated with
            study suggested that dogs infected with D. immitis and   their co‐infecting  Wolbachia, but it is unclear if
            seropositive for WSP were more likely to have proteinu-  Wolbachia can cause disease without the presence of
            ria than WSP‐seronegative dogs.                   filarial nematodes.


              Further Reading

            American Heartworm Association. Current canine    Morchon R, Carreton E, Grandi G, et al.
              guidelines for the diagnosis, prevention, and     Anti‐Wolbachia surface protein antibodies are present
              management of heartworm (Dirofilaria immitis)     in the urine of dogs naturally infected with Dirofilaria
              infection in dogs. www.heartwormsociety.org/      immitis with circulating microfilariae but not in dogs
              veterinary‐resources/canine‐guidelines.html (accessed   with occult infections. Vectorborne Zoonot Dis 2012;
              June 24, 2019).                                   12: 17–20.
            Frank K, Heald RD. The emerging role of Wolbachia   Nelson CT. Wolbachia pipientis infection. In: Greene CE,
              species in heartworm disease. Compendium 2010; 32: E4.  ed. Infectious Diseases of the Dog and Cat, 4th edn. St
            Garcia‐Guasch L, Caro‐Vadillo A, Manubens‐Grau J, et al.   Louis, MO: Elsevier Saunders, 2012, pp. 225–6.
              Is Wolbachia participating in the bronchial reactivity of   Taylor MJ, Boronin D, Johnston K, et al. Wolbachia filarial
              cats with heartworm associated respiratory disease? Vet   interactions. Cellular Microbiology 2013; 15(4):
              Parasitol 2013; 196: 130–5.                       520–526.
   975   976   977   978   979   980   981   982   983   984   985